140 related articles for article (PubMed ID: 35044760)
1. Anti-Parkinson's Disease Activity of
Li X; Gao D; Paudel YN; Li X; Zheng M; Liu G; Ma Y; Chu L; He F; Jin M
ACS Chem Neurosci; 2022 Feb; 13(3):330-339. PubMed ID: 35044760
[TBL] [Abstract][Full Text] [Related]
2. Co-treatment with natural HMGB1 inhibitor Glycyrrhizin exerts neuroprotection and reverses Parkinson's disease like pathology in Zebrafish.
Ren Q; Jiang X; Paudel YN; Gao X; Gao D; Zhang P; Sheng W; Shang X; Liu K; Zhang X; Jin M
J Ethnopharmacol; 2022 Jun; 292():115234. PubMed ID: 35358621
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of Tongtian oral liquid, a Traditional Chinese Medicine in the Parkinson's disease-induced zebrafish model.
Dongjie S; Rajendran RS; Xia Q; She G; Tu P; Zhang Y; Liu K
Biomed Pharmacother; 2022 Apr; 148():112706. PubMed ID: 35152046
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of chlorogenic acid on Parkinson's disease like symptoms through boosting the autophagy in zebrafish.
Gao X; Zhang B; Zheng Y; Liu X; Rostyslav P; Finiuk N; Sik A; Stoika R; Liu K; Jin M
Eur J Pharmacol; 2023 Oct; 956():175950. PubMed ID: 37544423
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ
Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of YIAEDAER peptide against Parkinson's disease like pathology in zebrafish.
Ren Q; Jiang X; Zhang S; Gao X; Paudel YN; Zhang P; Wang R; Liu K; Jin M
Biomed Pharmacother; 2022 Mar; 147():112629. PubMed ID: 35030435
[TBL] [Abstract][Full Text] [Related]
7. Neuro-Restorative Effect of Nimodipine and Calcitriol in 1-Methyl 4-Phenyl 1,2,3,6 Tetrahydropyridine-Induced Zebrafish Parkinson's Disease Model.
Kim MJ; Cho SH; Seo Y; Kim SD; Park HC; Kim BJ
J Korean Neurosurg Soc; 2023 Dec; ():. PubMed ID: 38130142
[TBL] [Abstract][Full Text] [Related]
8. Mulberry fruit ameliorates Parkinson's-disease-related pathology by reducing α-synuclein and ubiquitin levels in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model.
Gu PS; Moon M; Choi JG; Oh MS
J Nutr Biochem; 2017 Jan; 39():15-21. PubMed ID: 27741433
[TBL] [Abstract][Full Text] [Related]
9. The molecular mechanism of three novel peptides from C-phycocyanin alleviates MPTP-induced Parkinson's disease-like pathology in zebrafish.
Xu FH; Qiu YZ; Zhang Y; Yang FH; Ji MM; Liu KC; Jin M; Zhang SS; Li B
Food Funct; 2023 Jul; 14(13):6157-6171. PubMed ID: 37337786
[TBL] [Abstract][Full Text] [Related]
10. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
11. Morphine attenuates neurotoxic effects of MPTP in zebrafish embryos by regulating oxidant/antioxidant balance and acetylcholinesterase activity.
Cansız D; Ustundag UV; Unal I; Alturfan AA; Emekli-Alturfan E
Drug Chem Toxicol; 2022 Nov; 45(6):2439-2447. PubMed ID: 34340603
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo.
Guo B; Xu D; Duan H; Du J; Zhang Z; Lee SM; Wang Y
Biol Pharm Bull; 2014; 37(2):274-85. PubMed ID: 24305623
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.
Ghosh A; Kanthasamy A; Joseph J; Anantharam V; Srivastava P; Dranka BP; Kalyanaraman B; Kanthasamy AG
J Neuroinflammation; 2012 Oct; 9():241. PubMed ID: 23092448
[TBL] [Abstract][Full Text] [Related]
14. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.
Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R
Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482
[TBL] [Abstract][Full Text] [Related]
15. Integrative multilevel exploration of the mechanism by which Er-Zhi-Wan alleviates the Parkinson's disease (PD)-like phenotype in the MPTP-induced PD mouse model.
Pan B; Niu B; He Y; Zhou C; Xia C
Biomed Pharmacother; 2023 Sep; 165():115021. PubMed ID: 37348406
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin protects dopaminergic neurons against MPTP neurotoxicity through promoting autophagy and inhibiting endoplasmic reticulum mediated apoptosis.
Wang H; Dou S; Zhu J; Shao Z; Wang C; Cheng B
Brain Res; 2020 Nov; 1746():147023. PubMed ID: 32710901
[TBL] [Abstract][Full Text] [Related]
17. Human Amniotic Epithelial Cells Alleviate a Mouse Model of Parkinson's Disease Mainly by Neuroprotective, Anti-Oxidative and Anti-Inflammatory Factors.
Zhang J; Li H; Yang H; Lin J; Wang Y; Zhang Q; Gao WQ; Xu H
J Neuroimmune Pharmacol; 2021 Sep; 16(3):620-633. PubMed ID: 33164162
[TBL] [Abstract][Full Text] [Related]
18. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.
Liu L; Peritore C; Ginsberg J; Shih J; Arun S; Donmez G
Behav Brain Res; 2015 Mar; 281():215-21. PubMed ID: 25541039
[TBL] [Abstract][Full Text] [Related]
19. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
Katila N; Bhurtel S; Shadfar S; Srivastav S; Neupane S; Ojha U; Jeong GS; Choi DY
Neuropharmacology; 2017 Oct; 125():396-407. PubMed ID: 28807678
[TBL] [Abstract][Full Text] [Related]
20. Papaverine inhibits α-synuclein aggregation by modulating neuroinflammation and matrix metalloproteinase-3 expression in the subacute MPTP/P mouse model of Parkinson's disease.
Leem YH; Park JS; Park JE; Kim DY; Kang JL; Kim HS
Biomed Pharmacother; 2020 Oct; 130():110576. PubMed ID: 32768884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
